<qa>  What is the name of the MM TRANSPLANT INELIGIBLE PATIENTSUSE LENALIDOMIDE REVLIMID IN COMBINATION WITH DEXAMETHASONE IN CLINICAL PRACTICE FOR THE TREATMENT OF NEWLY DIAGNOSED MULTIPLE MYELOMA MM TRANSPLANT INELIGIBLE PATIENTS: 